ロード中...
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and is now the standard treatment for several different types of cancer, supported by favorable outcomes and good tolerance. However, it is linked to multiple immune manifestations, referred to as immune-related adverse event...
保存先:
| 出版年: | Gastroenterol Rep (Oxf) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034236/ https://ncbi.nlm.nih.gov/pubmed/32104583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goz065 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|